Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 393-395

  Hofmann, Christian ^a   Hüser, Andreas ^a   Lehnert, Wolfgang ^a   Strauss, Michael ^b,c  

^a HepaVec GmbH   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Baculovirus vectors; Hepatocytes; Liver gene transfer; Protection; Soluble complement receptor

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; MUTANT PROTEIN; RECOMBINANT RECEPTOR; VIRUS VECTOR;

ARTICLE; BACULOVIRUS; COMPLEMENT SYSTEM; GENE TRANSFER; IN VIVO STUDY; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; SERUM; VIRUS INACTIVATION;

UNIDENTIFIED BACULOVIRUS;

EID: 0344938224     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.052     Document Type: Article

References (20)

1. Barsoum, J., Brown, R., McKee, M., and Boyce, F.M. (1997). Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8, 2011-2018.
2. Boyce, F.M., and Bucher, N.L. (1996). Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93, 2348-2352.
3. Crossen, R., and Gruenwald, S. (1996). Baculovirus expression vector system manual. (San Diego, CA, USA: PharMingen).
4. Hofmann, C., and Strauss, M. (1998). Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5, 531-536.
5. Hofmann, C., Sandig, V., Jennings, G., Rudolph, M., Schlag, P., and Strauss, M. (1995). Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92, 10099-10103.
6. Hofmann, C., Lehnert, W., and Strauss, M. (1998). The baculovirus vector system for gene delivery into hepatocytes. Gene Ther. Mol. Biol. 1, 231-239.
7. Kirschfink, M. (1997). Controlling the complement system in inflammation. Immunopharmacol. 38, 51-62.
8. Marjan, J., Xie, Z., and Devine, D.V. (1994). Liposome-inducedactivation of the classical complement pathway does not require immunoglobulin. Biochim. Biophys. Acta 1192, 35-44.
9. O'Reilly, O.R., Miller, L.K., and Luckow, V.A. (1994). Virus host interactions. In: Baculovirus Expression Vectors: A Laboratory Manual. (New York, Oxford: Oxford University Press), p. 29.
10. Palombo, F., Monciotti, A., Recchia, A., Cortese, R., Ciliberto, G., and La Monica, N. (1998). Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72, 5025-5034.
11. Plank, C., Mechtler, K., Szoka, F.C., Jr., and Wagner, E. (1996). Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7, 1437-1446.
12. Sandig, V., and Strauss, M. (1996). Liver-directed gene transfer and application to therapy. J. Mol. Med. 74, 205-212.
13. Sandig, V., Hofmann, C., Steinert, S., Jennings, G., Schlag, P., and Strauss, M. (1996). Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7, 1937-1945.
14. Scesney, S.M., Makrides, S.C., Gosselin, M.L., Ford, P.J., Andrews, B.M., Haymann, E.G., and Marsh, H.C. (1995). Asoluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. FASEB J. 9, A807.
15. Shoji, I., Aizaki, H., Tani, H., Ishii, K., Chiba, T., Saito, I., Miyamura, T., and Matsuura, Y. (1997). Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78, 2657-2664.
16. Szebeni, J., Wassef, N.M., Spielberg, H., Rudolph, A.S., and Alving, C.R. (1994). Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for antilipid antibodies and alternative pathway activation. Biochem. Biophys. Res. Commun. 205, 255-263.
17. Takeuchi, y., Porter, C.D., Strahan, K.M., Preece, A.F., Gustafsson, K., Cosset, F-L., Weiss, R.A., and Collins, M.K.L. (1996). Sensitization of cells and retroviruses to human serum by (α1-3)galatosyltransferase. Nature 379, 85-88.
18. Weisman, H.F., Bartow, T., Leppo, M.K., Marsh, H.C., Jr., Carson, G.R., Concino, M.F., Boyle, M.P., Roux, K.H., Weisfeldt, M.L., and Fearon, D.T. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
19. Welsh, R.M., Jr., Cooper, N.R., Jensen, F.C., and Oldstone, M.B. (1975). Human serum lyses RNA tumour viruses. Nature 257, 612-614.
20. Yap, C., Ishii, K., Aoki, Y., Aizaki, H., Hideki, T., Shimizu, H., Ueno, Y., Miyamura, T., and Matsuura, Y. (1997). A hybrid baculovirus-T7 RNA polymerase system for recovery of an infectious virus from cDNA. Virology 231, 192-200.